In addition to the gag, pol, and env genes, which are present in the genomes of all retroviruses, human immunodeficiency viruses (HIV) and simian immunodeficiency viruses (SIV) express at least five regulatory proteins. The genes tat and rev are essential for virus replication, while vif, nef, vpu, vpr, and vpx can be dispensable in vitro. The fact that the reading frames of the auxiliary genes are conserved suggests that they are important in vivo, as recently demonstrated for the nef gene (16) . The accessory protein Vpr is highly conserved among all primate immunodeficiency viruses (23) . It is incorporated into the virus particle by association with the Gag protein (3, 21, 29, 30) , suggesting a function of Vpr early in the viral replication cycle. An arginine-rich sequence in the carboxy-terminal part of Vpr functions as a nuclear localization signal in the absence of Gag (21) . Vpr facilitated the nuclear localization of viral nucleic acids in growth-arrested cells, and, therefore, it was suggested that Vpr supports the translocation of the preintegration complex from the cytoplasm to the nucleus of nondividing cells (12) . This might explain the impaired replication of vpr-deficient HIV-1 and HIV-2 strains in macrophages (1, 11, 12, 14) , but not in T-cell lines and peripheral blood mononuclear cells (PBMCs) (10, 18) . However, replication of a macrophage-tropic variant of SIVmac239 in macrophages was not significantly affected by vpr (10) . In addition to the vpr gene, SIV and HIV-2 contain the closely related gene vpx. An overlapping function of these genes in SIV could explain the unimpaired replication of SIVmac239 vpr mutants in macrophages. The Vpr of HIV-1 was also reported to transactivate the HIV-1 long terminal repeat and a number of heterologous promoters (4) and to induce cell differentiation in a rhabdomyosarcoma cell line (19) .
Little is known about the function of vpr for virus replication in vivo and for pathogenesis. In previous experiments, two of three animals infected with SIVmac239 containing a point mutation in the vpr gene developed disease after the mutated vpr gene had reverted to a functional vpr gene early after infection (18) . The function of vpr in vivo was now investigated by analyzing the course of infection in animals in which the vpr point mutation had not reverted during the first year after inoculation and by infecting rhesus monkeys with a SIVmac239 vpr deletion mutant.
MATERIALS AND METHODS
Construction of the SIVmac239 mutants. The molecular clone SIVmac239 carries the stop signal TAA at position 93 of the nef reading frame (25) . To obtain an open nef reading frame, we replaced a 469-bp NcoI-NdeI fragment (positions 9280 to 9749 according to the numbering system of reference 25) with a PCR-generated fragment spanning nef from a SIVmac239 isolate from an infected rhesus monkey. This change converted the TAA stop codon to CAA. The inserted nef gene also carries the silent point mutations AGT to AGC at codon 110 and CCA to CCG at codon 197. The resulting virus was called SIVmac239 open-nef (SIVmac239on). To construct a stable vpr-deficient virus, a subcloned SIVmac239 fragment containing the vpr reading frame was cleaved with NcoI and HindIII, blunt ended with T4 DNA polymerase, and religated. One of the clones obtained (SIV⌬vpr) had a 43-bp deletion in the vpr sequence from positions 6197 to 6239 (25) , which also generated two stop signals at codons 16 and 18 of the vpr reading frame.
Determination of immunological parameters. The humoral immune response of infected monkeys against viral antigens was determined by enzyme-linked immunosorbent assay (ELISA) and Western blotting (immunoblotting) with pelleted whole SIVmac251 as an antigen as described previously (27) . Urinary neopterin levels were measured as described previously (6) . The CD4/CD8 ratio in the PBMCs of infected animals was determined by fluorescence-activated cell sorter analyses with a fluorescein isothiocyanate-labelled anti-CD4 antibody (OKT4; Ortho Diagnostic Systems) and a fluorescein isothiocyanate-labelled anti-CD8 antibody (B9.11; Dianova, Hamburg, Germany). For the antigen-specific T-cell proliferation assays (28) , PBMCs were obtained from citrate-treated blood by Ficoll-diatrizoate density gradient centrifugation. The cells were seeded in microtiter plates (10 5 per well) in 100 l of CG medium (Vitromex, Vilshofen, Germany) supplemented with 1% human AB serum. Cells were stimulated with 0.25 g of purified heat-inactivated SIVmac251 or 1 g of keyhole limpet hemocyanin (KLH) for 7 days. During the last 6 h, 0.5 Ci of [ 3 H]thymidine was added per well. After the cells were harvested, the incorporated radioactivity was measured with a ␤-counter. The stimulation index was calculated from the mean counts of triplicate wells by dividing the mean counts of antigen-containing cultures by the mean counts of cultures without antigen. Stimulation indices over 2 were considered positive.
Virus cultures. To generate biologically active viruses, plasmid clones containing either the 5Ј half of the SIVmac239 proviral DNA (p239SpSp5Ј [15] ) or the 5Ј half of the SIV⌬vpr DNA were ligated via SphI sites to the 3Ј half of SIVmac239on proviral DNA. The ligation reaction mixture was transfected into CEMx174 cells, and virus was harvested as described previously (18) . The 50% tissue culture infective doses of the virus stocks obtained were determined on CEMx174 cells. For virus isolation, PBMCs were purified from citrate-treated blood by banding over a Ficoll gradient. Isolated PBMCs were stimulated with phytohemagglutinin (10 g/ml) overnight. The next day, cocultures with CEMx174 cells were set up in RPMI 1640 medium (Gibco BRL), supplemented with 10% heat-inactivated fetal calf serum (Gibco BRL), penicillin (100 U/ml), streptomycin (100 g/ml), glutamine (300 g/ml), and interleukin-2 (100 U/ml; Eurocetus). The minimal numbers of PBMCs required for virus isolation in cocultures with Mm5573/HVS488 cells or CEMx174 cells were determined as a measure of cell-associated virus titers. The Mm5573/HVS488 cell line is a rhesus monkey T-cell line immortalized by herpesvirus saimiri as described previously (2) . Virus replication was verified by measurement of the reverse transcriptase activity in culture supernatants (24) or by detection of viral antigens with a polyvalent antigen capture assay (Organon, Heidelberg, Germany). To isolate viral DNA from infected cells, Hirt extracts (13) were prepared shortly before peak syncytium formation. The amount of p27 capsid antigen in the plasma was determined with an antigen capture assay (Coulter Co.).
Infection of rhesus monkeys. Animals were housed at the German Primate Center in Göttingen, Germany. Handling of the monkeys and collection of specimens were performed according to institutional guidelines as described previously (26) . Four rhesus monkeys of Indian origin (seronegative for SIV, D-type retroviruses, and STLV-1) were infected intravenously with 8 ϫ 10 4 50% tissue culture infective doses of SIV⌬vpr; two animals received 4 ϫ 10 4 tissue culture infective doses of SIVmac239on as a control. Animals were euthanized when they developed cachexia, persistent anorexia, or severe respiratory symptoms. According to general in-house rules, all animals developing diarrhea were treated once for 10 days with the antiprotozoic agent paromomycine, which is effective in stress-induced diarrhea. Stress-induced diarrhea is sometimes observed in uninfected animals and is accompanied by massive excretion of protozoa. In SIV-infected animals, paromomycine therapy usually fails, indicating an opportunistic infection. Animals 5573⌬ and 5568⌬ developed therapy-resistant diarrhea with large amounts of Giardia lamblia cysts in their feces approximately 2 weeks prior to euthansia.
PCR amplifications and DNA sequencing. vpr-and vpx-spanning fragments were generated by PCR from Hirt DNA from infected cells and subcloned in the plasmid pBS(Ϫ) (Stratagene). The sequences of the specific oligonucleotides and the conditions of the PCR were described previously (18) . The nucleotide sequence was determined with an ABI-373a automated sequencer by using dyelabelled dideoxynucleotides according to protocols provided by the manufacturer (Applied Biosystems).
RESULTS
Follow-up of animals showing late reversion of the SIV vpr gene. Previously, five rhesus monkeys were inoculated with SIVmac239 virus containing a point mutation of the vpr initiation codon (SIVvpr Ϫ ) and a premature termination codon in nef (18) . Two animals were infected with SIVmac239, which also contains the premature termination codon in nef. The nef termination codon of the viral genome reverted within 4 weeks in all animals. In three animals infected with SIV vpr Ϫ , the viral genome had reverted to a functional vpr 16 weeks postinfection, and two animals had to be euthanized 40 and 46 weeks postinfection because of AIDS-related symptoms (18) . In two animals infected with SIVvpr Ϫ (HR69 and HR70), reversion to a functional vpr gene was not observed 58 (18) and 66 weeks postinfection, when six independent vpr clones from each virus reisolate were sequenced. However, 70 weeks postinfection, reversion was detected by PCR and partial sequence analysis in four of four clones from each animal. Reversion of the vpr genotype was confirmed for animal HR69 at 82, 86, 90, and 94 weeks postinfection. In the case of animal HR70, reversion was confirmed by sequencing the vpr gene of a virus reisolate recovered at week 90 and by sequencing the vpr genes amplified directly from PBMCs at weeks 78 and 94. In Western blot analyses, both animals had antibodies to Vpr 78 weeks postinfection (data not shown), which had not been detectable on week 58 (18) . Therefore, the vpr gene must have reverted in both animals more than a year after infection.
One of these animals (HR70) had a low virus burden and normal CD4/CD8 ratios (Table 1) . No clinical alterations were observed. In contrast, animal HR69 showed high cell-associated virus loads (Table 1) and developed a progressive lymphadenopathy. Histological analysis of a lymph node biopsy removed 146 weeks postinfection revealed an extreme follicular hyperplasia, signs of follicular fragmentation with single atrophic follicles, and a plasmacytosis. A slow decline in the CD4/ CD8 ratio could also be observed in this animal ( of vpr on virus load and pathogenesis in vivo, four rhesus monkeys were infected with SIV⌬vpr (1728⌬, 5568⌬, 5573⌬, and 5574⌬), while two animals received SIVmac239on (1733wt and 5577wt) as a control. To quantitate the cell-associated virus load in the infected monkeys, the minimal number of PBMCs required for virus isolation was determined (Table 2 ). In three of the four monkeys infected with SIV⌬vpr, cellassociated virus titers were similar to the titers observed in SIVmac239on-infected animals. In the fourth monkey infected with SIV⌬vpr (5574⌬), virus could be isolated during the first 20 weeks and on only two occasions thereafter. Antigenemia was never detected in this animal, in contrast with the other monkeys infected with SIV⌬vpr, which all had detectable p27 capsid antigen in the plasma at 2 weeks postinfection.
SIVmac239on-infected animals had persistent antigenemia throughout the observation period (Table 3) . Two animals (5568⌬ and 5573⌬) became antigenemic 56 and 64 weeks postinfection. Clinical alterations and pathology. The two rhesus monkeys infected with SIVmac239on had to be euthanized at 20 and 30 weeks postinfection because of severe respiratory symptoms, anorexia, and poor health. The autopsies revealed a massive Pneumocystis carinii pneumonia, atrophy of T-cell areas of the lymphatic tissues, and a nearly complete loss of germinal centers of the lymph nodes in both animals. Three of the four animals infected with SIV⌬vpr (5568⌬, 5573⌬, and 1728⌬) developed a transient, mild-to-moderate lymphadenopathy 10 to 28 weeks postinfection. Lymph node biopsies taken from the SIV⌬vpr-infected animals 48 weeks postinfection revealed a mild follicular hyperplasia, with the exception of 5573⌬, which had a more prominent follicular hyperplasia. Animals 5568⌬ and 5573⌬ had to be sacrificed 71 and 73 weeks postinfection, respectively, because of therapy-resistant diarrhea and cachexia. Similar to SIVmac239on-infected animals, massive P. carinii pneumonia, atrophy of the T-cell areas of the lymphatic tissues, and nearly complete loss of the germinal centers of the lymph nodes were observed in both animals. Other pathological findings included pharyngeal and esophageal candidiasis, duodenal and cholangeal cryptosporidiosis, and microspirochetosis of the cecum and colon ascendens. Two of the animals infected with SIV⌬vpr (1728⌬ and 5574⌬) were still alive 105 weeks postinfection without showing any clinical signs of immunodeficiency. A decline in the CD4/CD8 ratio in SIVmac 239on-infected monkeys was observed 12 and 16 weeks postinfection ( Table 4) . As repeatedly observed in rapidly progressing SIV-infected macaques, the decline in the CD4/CD8 ratio was not severe (17, 20) . In one of the SIV⌬vpr-infected animals which progressed to disease (5568⌬), a drop in the CD4/ CD8 ratio was observed 28 weeks postinfection. The other three animals infected with SIV⌬vpr (1728⌬, 5573⌬, and 5574⌬) did not show a severe decline in the CD4/CD8 ratio, although CD4/CD8 ratios below 0.8 could be observed in animals with high virus loads (1728⌬ and 5573⌬) at some time points. In 63 uninfected macaques, which were analyzed in the German Primate Center during these experiments, the CD4/ CD8 ratios were always higher than 0.9, and in only two cases were ratios below 1 observed (data not shown).
Follow-up of immunological parameters.
To analyze whether immunological alterations in SIV⌬vpr-infected animals are similar to the alterations in SIVmac239on-infected animals, a number of parameters were determined at regular intervals. Western blot analyses revealed that rhesus monkeys infected with SIV⌬vpr developed a strong humoral immune response against Gag, Pol, and Env, while antibody formation was very weak in SIVmac239on-infected animals (Fig. 1A) . In animals 5568⌬ and 5573⌬, a decline in the number of antibodies against the p27 capsid antigen could be observed at 32 weeks postinfection. To quantitate the antibody titers more precisely, a SIV whole-virus ELISA was performed (Fig. 1B) . In animals infected with SIV⌬vpr, antibody titers were approximately 100-fold higher than in animals infected with SIVmac239on.
Because of the marked differences in the humoral immune response to SIV antigens in SIVmac239on-and SIV⌬vpr-infected animals, the cellular immune response was also analyzed in antigen-specific T-cell proliferation assays (Fig. 2) . After KLH immunization, 20 weeks postinfection, KLH-specific T-cell proliferation could only be detected in animals infected with SIV⌬vpr but not in the SIVmac239on-infected animal that was still alive at that time ( Fig. 2A) . The KLH response in animals infected with SIV⌬vpr is similar to the response of uninfected animals (data not shown). The T-cell proliferation in response to SIV antigens was also analyzed at different time points after infection (Fig. 2B ). SIVmac239on-infected animals never showed significant SIV antigen-specific proliferation of their T cells. However, an intermittent reactivity was observed for all animals infected with SIV⌬vpr. The two animals progressing to disease (5568⌬ and 5573⌬) had lost their SIV antigen-specific T-cell response 68 weeks postinfection. Neopterin is released from activated T cells and macrophages. During the acute phase of infection with immunodeficiency viruses and with progression to disease, neopterin levels are elevated (6, 7) . Elevated neopterin levels could be a consequence of a cytokine dysregulation leading to T-cell and macrophage activation as discussed previously (8) . Therefore, urinary neopterin levels were determined as a marker for disease progression and immune stimulation (Fig. 3) . Neopterin values increased in all animals between 5 and 15 days postinfection, reaching peak levels up to 16-fold above baseline. After this initial peak, neopterin concentrations declined at close to baseline values in the four animals that received SIV⌬vpr, while the neopterin levels remained elevated in SIVmac239on-infected monkeys. In all animals that progressed to disease, increases in neopterin levels were observed approximately 3 months before death.
AIDS in the absence of vpr. To confirm the progression to AIDS in the absence of Vpr, the vpr genes of virus isolates recovered from the PBMCs of animals 5568⌬ and 5573⌬ on the day of death were cloned and sequenced. All five clones that were sequenced from each animal still contained the deletion followed by the two stop codons introduced. While there were a number of point mutations throughout the vpr gene, none of them led to the development of an ATG start codon (data not shown). Three of the clones sequenced from animal 5573⌬ had a small additional deletion upstream of the tat initiation codon. Three bases (positions 6295 to 6297 in the numbering of reference 25) were deleted in one of the clones, and a 2-bp deletion (positions 6256 and 6257) was observed in two clones. An additional start codon was not introduced by these deletions. Virus reisolates recovered approximately 1 year after infection from the two animals that are still alive had also retained the deletion in the vpr gene.
DISCUSSION
In contrast with results obtained with a nef deletion variant of SIVmac239 (16), vpr is clearly not required for pathogenicity. Two out of four animals infected with SIV⌬vpr developed an AIDS-like disease, as demonstrated by a decline in the CD4/CD8 ratio, a loss of SIV antigen-specific T-cell proliferation, an increase in urinary neopterin levels, the occurrence of opportunistic infections, and the finding of characteristic histopathological alterations of the lymphatic tissue. A high virus burden and decreasing SIV antigen-specific T-cell proliferation might indicate the progression to disease in the third animal infected with SIV⌬vpr. One of the four animals infected with SIV⌬vpr had a very low cell-associated virus load and showed no signs of progression to AIDS.
Both animals infected with SIVmac239on died with AIDS 20 and 30 weeks postinfection. Two of the four animals infected with SIV⌬vpr died 71 and 73 weeks postinfection. The two remaining animals were still alive 105 weeks postinfection. Therefore, progression to AIDS might be delayed in the absence of vpr. In our previous study, in which two animals had been infected with SIVmac239 and five animals had been infected with SIVvpr Ϫ , which contains a point mutation of the start codon of vpr, a similar tendency was observed (18) . Both viruses used in this study had a premature stop codon, which quickly reverted in vivo. The two wild-type-infected animals died within the first year. Two of the five animals infected with the vpr deletion mutant were still alive 203 weeks postinfection and showed no signs of clinical immunodeficiency. In summary, four of nine animals infected with SIVmac239 vpr deletion mutants survived longer than 2 years, whereas four of four animals infected with viruses containing a functional vpr died within the first year postinfection. These observations may suggest an influence of vpr on the course of disease in SIVinfected rhesus monkeys. However, because of the limited number of animals available for these studies, it is not yet possible to firmly conclude that progression to AIDS is delayed in the absence of vpr.
In a recent study, J. S. Gibbs and coworkers also observed induction of AIDS in SIV-infected rhesus monkeys in the absence of vpr (9) . In these experiments, the behavior of a SIVmac239 vpr deletion mutant was similar to that of the parental, wild-type virus, and none of four animals infected with SIVmac239 died within the first year. In previously published studies, approximately 50% of the animals infected with SIVmac239 are rapid progressors, which do not develop a strong antibody response and which die within the first year (15, 16, 20, 22) . In our experiments, all animals infected with SIVmac239 variants containing a functional vpr gene were rapid progressors, suggesting that the monkeys used in our study could have been particularly sensitive to rapid progression to disease. As noted before (20) , the source of the rhesus monkeys can have a strong influence on the course of disease after infection with the same SIVmac stocks. Therefore, the differences between our studies and the study of Gibbs et al. could be explained if vpr had an influence only on rapid progression to disease. In animals in which the course of the disease is slower for other reasons, a supportive effect of vpr would then be less prominent. In addition to the vpr gene, SIV contains the closely related gene vpx. An overlapping function of these genes might be an explanation for the progression to disease in the absence of vpr. The observation that SIVmac239 vpr and vpx deletion mutants are more severely attenuated than single deletion mutants (9) is consistent with this hypothesis. The course of the disease in animals infected with SIV⌬vpr differed from the one observed in SIVmac239on-infected animals in a number of parameters. SIVmac239on-infected animals had persistent antigenemia, hardly any antibody response, and no antigen-specific T-cell proliferation. In contrast, in the first year, antigen could only be detected 2 weeks postinfection in three of the four animals infected with SIV⌬vpr, although the cell-associated virus load in these three animals was similar to that in SIVmac239on-infected animals. The strong antibody response to the p27 capsid antigen in SIV⌬vpr-infected animals probably prevents the detection of the p27 antigen. In addition to a strong humoral immune response, antigen-specific T-cell proliferation could be intermittently detected in SIV⌬vpr-infected animals but not in SIVmac239on-infected animals. In previous experiments, macaques infected with nonpathogenic HIV-2 had acquired a SIV antigen-specific T-cell proliferation, which was not observed in animals infected with pathogenic SIVmac251, suggesting a partially attenuated phenotype of the vpr deletion mutant (5) .
The causes of the observed differences in the immune responses are not understood. An immunosuppressive effect of vpr could explain the strong immune responses against SIV observed in the absence of vpr. Since high-level antibody responses were also observed in animals that progress slowly after infection with SIVmac239 in the presence of vpr (15), we suggest that a less-efficient replication of vpr-deficient SIVmac239 in certain cell types in vivo could result in a more vigorous immune response. The immune responses of some animals might then be able to control virus replication for an extended period of time, even after reversion to a functional vpr gene.
